These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35741624)

  • 1. Not just a Snapshot: An Italian Longitudinal Evaluation of Stability of Gut Microbiota Findings in Parkinson's Disease.
    Cerroni R; Pietrucci D; Teofani A; Chillemi G; Liguori C; Pierantozzi M; Unida V; Selmani S; Mercuri NB; Stefani A
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
    Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
    Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation.
    Kuai XY; Yao XH; Xu LJ; Zhou YQ; Zhang LP; Liu Y; Pei SF; Zhou CL
    Microb Cell Fact; 2021 May; 20(1):98. PubMed ID: 33985520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysbiosis of gut microbiota in a selected population of Parkinson's patients.
    Pietrucci D; Cerroni R; Unida V; Farcomeni A; Pierantozzi M; Mercuri NB; Biocca S; Stefani A; Desideri A
    Parkinsonism Relat Disord; 2019 Aug; 65():124-130. PubMed ID: 31174953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of Gut Microbial Metabolites in the Systemic Circulation of Patients with Parkinson's Disease.
    Chen SJ; Chen CC; Liao HY; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    J Parkinsons Dis; 2022; 12(4):1219-1230. PubMed ID: 35342048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota from patients with Parkinson's disease causes motor deficits in honeybees.
    Zeng J; Li Y; Yan J; Chang R; Xu M; Zhou G; Meng J; Liu D; Mao Z; Yang Y
    Front Microbiol; 2024; 15():1418857. PubMed ID: 39070266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson's disease.
    Nishiwaki H; Ito M; Hamaguchi T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Yoshida T; Hanada H; Takeuchi I; Katsuno M; Hirayama M; Ohno K
    NPJ Parkinsons Dis; 2022 Jun; 8(1):65. PubMed ID: 35650236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Uric Acid in LRRK2 Related Parkinson's Disease: Longitudinal Data from the PPMI Study.
    Bougea A; Koros C; Papagiannakis N; Simitsi AM; Prentakis A; Papadimitriou D; Pachi I; Antonelou R; Angelopoulou E; Beratis I; Bozi M; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2021; 11(2):633-640. PubMed ID: 33682725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease.
    Yang X; Qian Y; Xu S; Song Y; Xiao Q
    Front Aging Neurosci; 2017; 9():441. PubMed ID: 29358918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease.
    Palacios N; Hannoun A; Flahive J; Ward D; Goostrey K; Deb A; Smith KM
    Front Neurol; 2021; 12():574529. PubMed ID: 33746867
    [No Abstract]   [Full Text] [Related]  

  • 13. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
    Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
    J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
    Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
    J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Nonmotor Changes in Patients with Parkinson's Disease and Motor Fluctuations: J-FIRST.
    Watanabe H; Saiki H; Chiu SW; Yamaguchi T; Kashihara K; Tsuboi Y; Nomoto M; Hattori N; Maeda T; Shimo Y;
    Mov Disord Clin Pract; 2020 May; 7(4):431-439. PubMed ID: 32373660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Metabolome Alterations Associated with Parkinson's Disease.
    Vascellari S; Palmas V; Melis M; Pisanu S; Cusano R; Uva P; Perra D; Madau V; Sarchioto M; Oppo V; Simola N; Morelli M; Santoru ML; Atzori L; Melis M; Cossu G; Manzin A
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32934117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China.
    Li C; Cui L; Yang Y; Miao J; Zhao X; Zhang J; Cui G; Zhang Y
    Front Mol Neurosci; 2019; 12():171. PubMed ID: 31354427
    [No Abstract]   [Full Text] [Related]  

  • 18. Does Gut Microbiota Influence the Course of Parkinson's Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
    Cilia R; Piatti M; Cereda E; Bolliri C; Caronni S; Ferri V; Cassani E; Bonvegna S; Ferrarese C; Zecchinelli AL; Barichella M; Pezzoli G
    J Parkinsons Dis; 2021; 11(1):159-170. PubMed ID: 33337387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
    Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
    Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
    Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
    Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.